No events found
We’ll display events we find for Retension Pharmaceuticals here
𝛼SK or SearchENTITY
Retension Pharmaceuticals (RTSN2 US)
Retension Pharmaceuticals (RTSN2 US)
2
Analysis
Health Care • United States
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.
morex